Sort
23,748 grants matching “melanoma”
University of Utah Medical Informatics Training
$281,516Joyce A Mitchell · University Of Utah · T15 · FY2007 · LM
GENE THERAPY STRATEGIES TO RADIOSENSITIZE HUMAN TUMOR CELLS
$281,477Raymond E Meyn · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Innate Factors in Tumor Antigen Cross-Presentation
$281,448Thomas F Gajewski · University Of Chicago · P01 · FY2008 · CA
Mechanistic Studies on New Platinum Clinical Agents
$281,400Nicholas P Farrell · Virginia Commonwealth University · R56 · FY2007 · CA
Components of Translation in Signal Transduction
$281,377Paul R Schimmel · Scripps Research Institute, The · R01 · FY2013 · CA
Analysis of Glycomic Regulators in Melanoma Progression
$281,320Charles J Dimitroff · Florida International University · U01 · FY2019 · CA
MECHANISMS OF UV-INDUCED MELANOMA INITIATION. NEW AWARD.
$281,316University Of Utah · · FY2020 · Defense Health Agency
The Antigen Targeting Core
$281,256Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
CANCER AND LEUKEMIA GROUP B--RPCI/SUNYAB
$281,252Roswell Park Cancer Institute Corp · U10 · FY2000 · CA
Targeting the LKB1-AMPK pathway in melanoma: Mechanism and preclinical evaluation
$281,243Bin Zheng · Massachusetts General Hospital · R01 · FY2013 · CA
PTD-Mediated Protein or Drug Delivery for Cancer Therapy
$281,240University Of Michigan At Ann Arbor · R01 · FY2005 · CA
KISS1: Defining Mechanisms for Antimetastatic Therapy
$281,227Danny R Welch · University Of Kansas Medical Center · R01 · FY2014 · CA
Clinically Useful Pronostic Models in Primary Melanoma
$281,204Phyllis A Gimotty · Wistar Institute · P50 · FY2008 · CA
HIGHLY INNOVATED TARGETED THERAPY OF MELANOMA
$281,165Raymond J Budde · Houston Pharmaceuticals, Inc. · R43 · FY2016 · CA
Admin Core
$280,990Iman Osman · New York University School Of Medicine · P50 · FY2023 · CA
Cytokine modulated model growth inhibitory mechanisms
$280,989Dhan V. Kalvakolanu · University Of Maryland Baltimore · R01 · FY2009 · CA
Project 1: Pathology of the Sentinel and Non-Sentinel Lymph Nodes
$280,983Alistair John Cochran · Saint John'S Cancer Institute · P01 · FY2008 · CA
Resistance to apoptosis in clinical melanoma gene therapy
$280,939Ali Jazirehi · University Of California Los Angeles · R21 · FY2011 · CA
IDENTIFICATION OF CD8+ T CELL TARGETS ON RENAL CANCER
$280,922Johns Hopkins University · R01 · FY2003 · CA
OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE
$280,910Cliona M Rooney · Baylor College Of Medicine · P01 · FY2010 · CA
Targeting ASAP1-Controlled Signal Pathways to Inhibit Uveal Melanoma Metastasis
$280,905Jae Hyuk Yoo · University Of Nebraska Medical Center · P20 · FY2023 · GM
Targeting ASAP1-Controlled Signal Pathways to Inhibit Uveal Melanoma Metastasis
$280,904Jae Hyuk Yoo · University Of Nebraska Medical Center · P20 · FY2024 · GM
Project 1
$280,878Jiyoung Ahn · New York University School Of Medicine · P50 · FY2022 · CA
Project 1
$280,877Jiyoung Ahn · New York University School Of Medicine · P50 · FY2019 · CA
Project 1
$280,877Jiyoung Ahn · New York University School Of Medicine · P50 · FY2021 · CA